Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
Аннотация
Part I of this report appeared in the previous issue (Br. J. Cancer (1976) 34,585), and discussed the design of randomized clinical trials. Part II now describes efficient methods of analysis of randomized clinical trials in which we wish to compare the duration of survival (or the time until some other untoward event first occurs) among different groups of patients. It is intended to enable physicians without statistical training either to analyse such data themselves using life tables, the logrank test and retrospective stratification, or, when such analyses are presented, to appreciate them more critically, but the discussion may also be of interest to statisticians who have not yet specialized in clinical trial analyses.
Перевод полного текста: Перевод в очереди
Полный текст источника
https://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ .
Armitage P. Gehan E. A. Statistical methods for the identification and use of prognostic factors. 13 1 15 1 1974 16 36 Int J Cancer 4594339 10.1002/ijc.2910130104
Heyn R. M. Joo P. Karon M. Nesbit M. Shore N. Breslow N. Weiner J. Reed A. Hammond D. BCG in the treatment of acute lymphocytic leukemia. 46 3 9 1975 431 442 Blood 1056801
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. 50 3 3 1966 163 170 Cancer Chemother Rep 5910392
Mathé G. Amiel J. L. Schwarzenberg L. Schneider M. Cattan A. Schlumberger J. R. Hayat M. De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. 1 7597 5 4 1969 697 699 Lancet 4182654 10.1016/s0140-6736(69)92648-8
Peto R. Pike M. C. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. 29 3 9 1973 579 584 Biometrics 4793138
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.